FNY Managed Accounts’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-161
Closed -$2K 260
2017
Q1
$2K Buy
+161
New +$2K 0.01% 697